Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender.
Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender.
复制标题
DOI：
10.1016/j.amepre.2020.05.025
复制
发表时间：
2020-11
影响因子：
5.5
通讯作者：
Mauro PM
中科院分区：
文献类型：
--
作者：
Philbin MM;Greene ER;Martins SS;LaBossier NJ;Mauro PM
按性别划分的医疗和非医疗处方兴奋剂使用和非法兴奋剂使用(即可卡因/可卡因/冰毒)方面的主要知识差距对个人的健康和福祉有影响。这项研究通过区分兴奋剂使用的类型并关注女同性恋者、男同性恋者和双性恋者亚群来改进兴奋剂使用测量。2015-2017年全国毒品使用与健康调查(n=126,463；2019年分析)汇集了成年人的数据。性别分层Logistic回归模型检验性认同与过去一年非法兴奋剂使用之间的关系。性别分层多项Logistic回归模型估计的几率：(1)仅使用医疗药物与不使用过去一年的处方药；(2)使用任何常规兴奋剂与不使用过去一年的兴奋剂；以及(3)使用任何非医疗兴奋剂与仅使用医疗药物。非法使用兴奋剂因性别身份不同而不同(男性：男同性恋，9.2%；双性恋，7.5%；异性恋，3.2%；女性：男/女同性恋，3.2%；双性恋，7.8%；异性恋，1.5%)，非医疗处方兴奋剂的使用也是如此。与同性异性恋者相比，男同性恋者(AOR=2.61，95%CI=2.00，3.40)和双性恋者(AOR=1.70，95%CI=1.24，2.33)以及男女同性恋(AOR=1.63，95%CI=1.16，2.28)和双性恋者(AOR=2.70，95%CI=2.23，3.26)过去一年非法服用兴奋剂的几率较高。据报道，性少数群体使用非药物处方兴奋剂的几率高于异性恋。26.4%的报告非药物兴奋剂使用的人报告了任何非药物处方阿片类药物的使用，27.0%的人报告了非法使用兴奋剂的人。女同性恋者、男同性恋者和双性恋者比他们的异性恋者使用兴奋剂的流行率更高。这对健康差距有重要影响，特别是考虑到多种物质的高水平使用。采取多层次的方法对于减少兴奋剂对女同性恋者、男同性恋者和双性恋者的伤害至关重要。
Major knowledge gaps regarding medical and nonmedical prescription stimulant use and illegal stimulant use (i.e., cocaine/crack/methamphetamine) by sexual identity and gender have implications for individuals’ health and well-being. This study improves stimulant use measurement by differentiating type of stimulant use and focusing on lesbian, gay, and bisexual subpopulations. Data were pooled for adults in the 2015–2017 National Survey on Drug Use and Health (n=126,463; analyzed in 2019). Gender-stratified logistic regression models examined associations between sexual identity and past-year illegal stimulant use. Gender-stratified multinomial logistic regression models estimated odds of: (1) medical use only versus no past-year prescription stimulant use, (2) any nomnedical stimulant use versus no past-year use, and (3) any nonmedical stimulant use versus medical use only. Illegal stimulant use varied by sexual identity (men: gay, 9.2%; bisexual, 7.5%; heterosexual, 3.2%; women: gay/lesbian, 3.2%; bisexual, 7.8%; heterosexual, 1.5%), as did nonmedical prescription stimulant use. Relative to same-gender heterosexuals, gay (AOR=2.61, 95% CI=2.00, 3.40) and bisexual men (AOR=1.70, 95% CI=1.24, 2.33) had higher odds of past-year illegal stimulant use, as did gay/lesbian (AOR=1.63, 95% CI=1.16, 2.28) and bisexual women (AOR=2.70, 95% CI=2.23, 3.26). Sexual minorities reported higher odds of nonmedical prescription stimulant use than heterosexuals. Any nonmedical prescription opioid use was reported by 26.4% of people who reported nonmedical stimulant use, and 27.0% of people who reported illegal stimulant use. Lesbian, gay, and bisexual individuals had a higher prevalence stimulant use than their heterosexual counterparts. This has important implications for health disparities, particularly given high levels of polysubstance use. Taking a multilevel approach is crucial to reduce stimulant-related harms for lesbian, gay, and bisexual individuals.
登录
查看更多内容
影响因子：
2.3
作者：
Arria, Amelia M.;DuPont, Robert L.
通讯作者：
DuPont, Robert L.
影响因子：
3.1
作者：
Benotsch, Eric G.;Martin, Aaron M.;Luckman, Diana
通讯作者：
Luckman, Diana
影响因子：
9.7
作者：
Dowell, Deborah;Zhang, Kun;Hockenberry, Jason M.
通讯作者：
Hockenberry, Jason M.
影响因子：
4.8
作者：
Friedman, M. Reuel;Dodge, Brian;Reece, Michael
通讯作者：
Reece, Michael
影响因子：
7.2
作者：
Hatzenbuehler, Mark L.
通讯作者：
Hatzenbuehler, Mark L.